KR20060007083A - Whitening cosmetic composition containing rambutan extract and rambutan extraction method - Google Patents
Whitening cosmetic composition containing rambutan extract and rambutan extraction method Download PDFInfo
- Publication number
- KR20060007083A KR20060007083A KR1020040054936A KR20040054936A KR20060007083A KR 20060007083 A KR20060007083 A KR 20060007083A KR 1020040054936 A KR1020040054936 A KR 1020040054936A KR 20040054936 A KR20040054936 A KR 20040054936A KR 20060007083 A KR20060007083 A KR 20060007083A
- Authority
- KR
- South Korea
- Prior art keywords
- rambutan
- extract
- cosmetic composition
- whitening
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 244000183331 Nephelium lappaceum Species 0.000 title claims abstract description 92
- 239000000284 extract Substances 0.000 title claims abstract description 75
- 235000007861 rambutan Nutrition 0.000 title claims abstract description 73
- 239000000203 mixture Substances 0.000 title claims abstract description 55
- 230000002087 whitening effect Effects 0.000 title claims abstract description 47
- 239000002537 cosmetic Substances 0.000 title claims abstract description 41
- 238000000605 extraction Methods 0.000 title claims description 26
- 235000015738 Nephelium lappaceum Nutrition 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 30
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 29
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 230000002829 reductive effect Effects 0.000 claims description 17
- 238000001816 cooling Methods 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 13
- 238000004821 distillation Methods 0.000 claims description 11
- 238000009472 formulation Methods 0.000 claims description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- 230000032683 aging Effects 0.000 claims description 7
- 239000012044 organic layer Substances 0.000 claims description 7
- 239000003990 capacitor Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 5
- 150000001298 alcohols Chemical class 0.000 claims description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- -1 pack Substances 0.000 claims description 4
- 241000283690 Bos taurus Species 0.000 claims description 3
- 239000000686 essence Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000002274 desiccant Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims 1
- 238000001694 spray drying Methods 0.000 claims 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 20
- 102000003425 Tyrosinase Human genes 0.000 abstract description 15
- 108060008724 Tyrosinase Proteins 0.000 abstract description 15
- 230000008099 melanin synthesis Effects 0.000 abstract description 12
- 230000005764 inhibitory process Effects 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 5
- 230000007794 irritation Effects 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 31
- 230000002401 inhibitory effect Effects 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 18
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 17
- 238000002360 preparation method Methods 0.000 description 16
- 239000002994 raw material Substances 0.000 description 14
- 239000000706 filtrate Substances 0.000 description 12
- 239000010410 layer Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 229960000271 arbutin Drugs 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 9
- 206010040880 Skin irritation Diseases 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 8
- 230000036556 skin irritation Effects 0.000 description 8
- 231100000475 skin irritation Toxicity 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 208000012641 Pigmentation disease Diseases 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000019612 pigmentation Effects 0.000 description 6
- 206010014970 Ephelides Diseases 0.000 description 5
- 208000003351 Melanosis Diseases 0.000 description 5
- 201000001441 melanoma Diseases 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241001093760 Sapindaceae Species 0.000 description 2
- 206010070835 Skin sensitisation Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 231100000286 mucous membrane, eye irritation or corrosion testing Toxicity 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 231100000370 skin sensitisation Toxicity 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 229960004441 tyrosine Drugs 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241001620259 Nephelium chryseum Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 229940049657 cyclomethicone 5 Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000000554 iris Anatomy 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 231100000017 mucous membrane irritation Toxicity 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 231100000933 sensitization response Toxicity 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 람부탄(Nephelium lappaceum L, var. lappaceum) 추출물을 함유하는 미백화장료 조성물 및 람부탄 추출방법에 관한 것이다. The present invention relates to a whitening cosmetic composition and a method of extracting rambutan containing rambutan extract ( Nephelium lappaceum L, var. Lappaceum ).
본 발명의 람부탄 추출물을 함유하는 미백화장료 조성물은 피부흑과과정에 관여하는 티로시나제를 억제함과 동시에 멜라닌 생성을 억제하여 미백효능이 우수할 뿐만 아니라, 피부에 자극이 없는 물질로서 제품의 안정성 및 피부 안전성도 우수하다. The whitening cosmetic composition containing the rambutan extract of the present invention not only inhibits tyrosinase involved in the skin blackening process, but also inhibits melanin production, and is excellent in whitening efficacy and has no irritation to the skin. The safety is also excellent.
람부탄, 티로시나제 억제, 멜라닌 생성억제, 피부미백, 피부흑화Rambutan, Tyrosinase Inhibition, Melanin Inhibition, Skin Whitening, Skin Blackening
Description
본 발명은 람부탄(Nephelium lappaceum L, var. lappaceum, Rambatan) 추출물을 함유하는 미백화장료 조성물 및 람부탄 추출방법에 관한 것으로, 보다 상세하게는 티로시나제를 억제함과 동시에 멜라닌 생성을 억제하여 미백작용이 우수한 람부탄(Nephelium lappaceum L.) 추출물을 함유하는 미백화장료 조성물 및 람부탄 추출방법에 관한 것이다.The invention rambutan (Nephelium lappaceum L, var. Lappaceum, Rambatan) relates to a whitening cosmetic composition and rambutan extraction containing extract, more particularly, to suppress melanin production and at the same time suppressing the tyrosinase it is excellent in whitening effect rambutan ( Nephelium lappaceum L.) relates to a whitening cosmetic composition containing the extract and rambutan extraction method.
피부는 인체의 일차 방어막으로서 체내의 제기관을 온도 및 습도 변화와 자외선, 공해물질 등 외부환경의 자극으로부터 보호해 주며, 체온조절 등의 생체 항상성 유지에 중요한 역할을 하고 있다. 그러나 세포 외부로부터 가해진 과도한 물리적 자극, 화학적 자극, 스트레스, 영양결핍, 자외선, 환경오염물질, 급격한 기온의 변화 등과 같은 세포손상자극은 세포내의 다양한 생화학적 변화를 유도하여 세포 손상 반응을 일으킨다. 이러한 피부 문제 중의 하나가 기미, 주근깨, 잡티 등의 피부흑화이다. Skin is the body's primary protective film that protects internal organs from changes in temperature and humidity, and from stimuli from the external environment such as ultraviolet rays and pollutants, and plays an important role in maintaining homeostasis such as body temperature control. However, cell damage, such as excessive physical stimuli, chemical stimuli, stress, malnutrition, ultraviolet radiation, environmental pollutants, and sudden changes in temperature caused from outside the cell, induce a variety of biochemical changes in the cell, causing a cell damage response. One such skin problem is skin blackening such as spots, freckles, and blemishes.
이러한 기미, 주근깨 등의 피부흑화는 멜라닌에 의한 영향이다. 피부의 외각인 표피층에 존재하는 멜라닌은 자외선 차단의 역할을 하여 진피 이하의 피부기관을 보호해주는 동시에 피부 생체 내에 생겨난 자유라디칼 등을 잡아주는 역할을 하여 피부내 단백질과 유전자들 보호해주는 유용한 역할을 한다. 피부가 자외선에 노출되면 아미노산의 일종인 티로신(tyrosine)에 티로시나제(tyrosinase)라는 효소가 작용하여, 도파(DOPA), 도파퀴논(dopaquinone)로 바뀐 후 비효소적인 산화반응에 의해 피부색소세포인 멜라노사이트(melanocyte)내의 멜라노좀(melanosome)에서 멜라닌이라는 중합체가 합성된다. 또한 피부에서 자유라디칼(free radical) 생성이 많아지거나 염증반응이 있거나 자외선 등을 받게 되면 멜라닌 생성은 증가된다. Such blackening of the skin, such as blemishes and freckles, is due to melanin. Melanin in the epidermal layer, which is the outer skin of the skin, acts as a sunscreen to protect the skin organs below the dermis and also to protect free radicals generated in the skin, thereby protecting proteins and genes in the skin. . When the skin is exposed to ultraviolet rays, an enzyme called tyrosinase acts on tyrosine, a kind of amino acid. In the melanosomes (melanocyte), a polymer called melanin is synthesized. In addition, the production of free radicals in the skin increases, melanin production increases when there is an inflammatory reaction or ultraviolet rays.
이러한 피부흑화의 원인과 기작이 밝혀지면서, 피부흑화과정에 관여하는 효소인 티로시나제를 저해하거나 멜라닌 중합반응을 억제하는 효능을 갖는 물질들이 화장료에 배합하여 사용되고 있다. 이러한 목적으로 사용되는 대표적인 물질로 히드로퀴논 (hydroquinone), 아스코르브산(ascorbic acid), 코지산(kojic acid), 또는 글루타치온(glutathione), 시스테인 등의 티올계 화합물, 알파히드록시산 등이 있다. 그러나 이러한 성분들 대부분이 그 자체가 불안정하거나, 미백효과가 미약하고 또한 피부에 자극을 유발하는 것으로 알려져 있다. 또한 미백효과가 있다고 알려진 천연 추출물은 활성성분이 미량 함유되어 있고, 산지나 수확시기에 따라 함량 변화가 심해 품질의 균질성을 갖기가 어려운 실정이며, 각종의 화합물이 함께 추출됨으로 인해 피부 부작용 및 색상 등에서의 단점을 지니고 있다. As the causes and mechanisms of skin blackening have been found, substances having an effect of inhibiting tyrosinase, an enzyme involved in skin blackening, or inhibiting melanin polymerization, have been used in cosmetics. Representative materials used for this purpose include a hydroquinone, ascorbic acid, kojic acid, or a thiol-based compound such as glutathione, cysteine, and alpha hydroxy acid. However, most of these ingredients are known to be unstable by themselves or have a weakening whitening effect and cause skin irritation. In addition, natural extracts known to have a whitening effect contain a small amount of active ingredients, and the content of the extract is severe depending on the place of production or the harvest time, making it difficult to have homogeneity of quality. Has the disadvantages.
상기와 같은 미약한 미백효과, 낮은 안정성, 피부자극 등의 기존의 멜라닌 생성 억제제들이 갖고 있는 문제점을 해결하기 위하여, 본 발명의 목적은 피부자극 없이 우수한 미백효과를 나타내는 람부탄 추출물을 함유하는 미백용화장료 조성물을 제공하는 것이다. In order to solve the problems of existing melanin production inhibitors such as weak whitening effect, low stability, skin irritation, the object of the present invention is a whitening cosmetic containing rambutan extract showing excellent whitening effect without skin irritation It is to provide a composition.
본 발명의 다른 목적은 람부탄 추출물의 유효성분의 함량을 높이고 피부 안전성을 증가시킬 수 있는 람부탄 추출방법을 제공하는 것이다.
Another object of the present invention is to provide a rambutan extraction method that can increase the content of the active ingredient of rambutan extract and increase skin safety.
상기 목적을 달성하기 위하여 본 발명은 람부탄(Nephelium lappaceum L, var. lappaceum) 추출물을 유효성분으로 함유하는 미백화장료 조성물을 제공한다. In order to achieve the above object, the present invention provides a whitening cosmetic composition containing rambutan extract ( Nephelium lappaceum L, var. Lappaceum ) as an active ingredient.
본 발명은 또한 (a) 람부탄 건조물에 탄소수 1~4의 무수, 또는 함수 저급 알코올, 물과 저급 알코올의 혼합물, 아세톤 및 1,3-부틸렌글리콜으로 이루어진 추출용매 중에서 하나 이상을 선택하여 부가한 다음 냉각콘덴서가 부착된 증류장치에서 50~200 ℃로 3 내지 24시간 동안 가열하여 추출하는 단계; (b) 상기 (a) 단계의 추출액을 4~25 ℃에서 1~10일간 방치하여 숙성시키는 단계; (c) 상기 (b) 단계의 숙 성액을 냉각콘덴서가 부착된 증류장치에서 50~90 ℃로 감압농축하여 에칠아세테이트, 디에틸에테르 및 메틸렌클로라이드로 이루어진 추출용매 중에서 하나 이상을 선택하여 1회 이상 추출하는 단계; 및, (d) 상기 (c) 단계의 추출액 중 유기층을 감압농축한 후 건조하는 단계; 를 포함하여 이루어지는 람부탄 추출물의 제조방법을 제공한다. The present invention also provides (a) adding at least one selected from an extract solvent consisting of anhydrous, hydrous lower alcohol, a mixture of water and lower alcohol, acetone and 1,3-butylene glycol having 1 to 4 carbon atoms to the rambutan dried product. Then extracting by heating for 3 to 24 hours at 50 ~ 200 ℃ in a distillation apparatus attached to the cooling capacitor; (b) aging the extract of step (a) for 1 to 10 days at 4 ~ 25 ℃; (c) the aging solution of step (b) is concentrated under reduced pressure at 50-90 ° C. in a distillation apparatus equipped with a cooling capacitor, and at least one time is selected from an extraction solvent consisting of ethyl acetate, diethyl ether and methylene chloride. Extracting; And (d) concentrating and drying the organic layer in the extract of step (c) under reduced pressure. It provides a method for producing a rambutan extract comprising a.
이하, 본 발명을 상세히 설명한다. Hereinafter, the present invention will be described in detail.
본 발명자들은 종래의 미백물질들이 갖는 미약한 미백효과, 낮은 안정성, 피부자극 등의 문제점을 극복하고 피부 부작용을 유발하지 않으면서 우수한 피부 미백효과를 갖는 천연물에 대하여 연구하던 중, 람부탄(Nephelium lappaceum L., Rambatan) 추출물이 미백효과가 있음을 밝혀내고 이의 안전성 및 효능을 극대화하기 위한 추출물 제조방법을 개발하여, 이를 토대로 본 발명을 완성하게 되었다. The present inventors have while trying to overcome the problems of weak bleaching effect, low stability, skin irritation with their conventional bleaching substances without causing the skin side effects research on natural products having excellent skin whitening effect, rambutan (Nephelium lappaceum L ., Rambatan) extract was found to have a whitening effect and developed an extract preparation method for maximizing its safety and efficacy, to complete the present invention based on this.
본 발명에 따른 미백화장료 조성물은 유효성분으로 람부탄 추출물을 함유한다. The whitening cosmetic composition according to the present invention contains a rambutan extract as an active ingredient.
람부탄(Nephelium lappaceum L, var. lappaceum, Rambatan)은 람부탄(Nephelium lappaceum L.)은 무환자나무과(Sapindaceae)에 속하는 식물로, 식물분류학상 N. glabrum Cambess., N. chryseum Blume, N. sufferrugineum Radlk.의 다른 이름(synonym)을 가지고 있다. 람부탄의 나무높이는 10~15m이며 잎은 어긋나고 5~7쌍으로 된 우상복엽(羽狀複葉)이며 두껍고 윤기가 나며 어릴때 뒷면에 털이 있 다. 꽃은 4~6월에 피며 2가화(二家花) 또는 잡성화이며, 황록색으로 원추화서(圓錐花序)에 달린다. 열매는 10~12개씩 모여서 달리며 작은 달걀만한 크기로서 7~8월에 홍색으로 익으며 육질돌기가 있다. 람부탄은 동남아시아의 열대과실 중 가장 많이 알려진 과실 중에 하나이고, 재배된 과실은 보통 생식으로 이용되며 시럽용으로 통조림형태 뿐만 아니라 잼이나 익힌 형태로 요리로도 이용된다. 람부탄의 과피에는 tannin과 saponin이 함유되어 있어 한약제로 사용되며, 이 밖에 뿌리는 감기를 치료하기 위한 약제로 사용되고 잎은 찜질약으로, 나무껍질은 혀에 병이 생겼을 때 근육을 완화시키는 치료제로도 사용한다. 그러나 이러한 람부탄의 추출물을 기미, 주근깨 및 다양한 색소침착 제거를 목적으로 미백화장료에 사용한 예는 없다.Rambutan (Nephelium lappaceum L, var. Lappaceum , Rambatan) is rambutan (Nephelium lappaceum L.) is. Examples of the plant belonging to sapindaceae (Sapindaceae), plants classified haksang glabrum Cambess N., N. chryseum Blume, N. sufferrugineum Radlk. Has a different name (synonym). Rambutan is 10 ~ 15m tall, leaves are alternate, 5 ~ 7 pairs of idol, and thick, glossy, with hair on the back when young. Flowers bloom in April-June and are biphasic (miscellaneous flowers) or hybrid flowers, and are yellowish green on the inflorescences (圓錐 花序). Fruits are gathered by 10-12 pieces and run as small eggs. They ripen in red in July-August and have meaty processes. Rambutan is one of the most well-known fruits of tropical fruits in Southeast Asia. Cultivated fruits are usually used for reproduction and can be used for cooking syrup as well as canned syrup. The skin of rambutan contains tannin and saponin, which is used as a herbal medicine. In addition, the root is used as a medicine to treat colds. The leaf is used as a poultice, and the bark is used to relieve muscles when the tongue develops. use. However, there is no example of using the extract of rambutan in whitening cosmetics for the purpose of removing blemishes, freckles and various pigmentation.
본 발명에 따른 람부탄(Nephelium lappaceum L.) 추출물은 피부자극 없이 피부흑화 과정에 관여하는 티로시나제를 억제함과 아울러 멜라닌 생성을 억제함으로써 우수한 피부미백효과를 나타낸다. 람부탄 추출물이 함유된 본 발명의 화장료조성물은 기미, 주근깨, 잡티 및 피부 그을림 등의 피부색소 침착 개선 및 예방에 사용될 수 있다. Rambutan (Nephelium lappaceum L.) extract according to the invention shows an excellent skin whitening effect by suppressing melanin production as well as inhibits the tyrosinase involved in skin blackening process without skin irritation. The cosmetic composition of the present invention containing rambutan extract can be used for improving and preventing skin pigmentation such as blemishes, freckles, blemishes and skin burns.
본 발명의 미백화장료 조성물은, 람부탄 추출물을 화장료 조성물 총 중량에 대하여 0.001 내지 10 중량%, 바람직하게는 0.01 내지 5 중량%의 양으로 함유하는 것을 특징으로 한다. 람부탄 추출물의 함량이 0.001 중량% 미만인 경우 피부미백효과가 미미하며, 10 중량%를 초과하는 경우 초과투입에 따른 상승효과가 적어 경제적이지 못하다. 한편 상기 람부탄 추출물은 과육과 과피를 포함하는 람부탄 과실 추출물을 사용할 수 있으며, 특히 람부탄 과피 추출물인 것이 피부미백효과면에서 바람직하다. The whitening cosmetic composition of the present invention is characterized by containing rambutan extract in an amount of 0.001 to 10% by weight, preferably 0.01 to 5% by weight based on the total weight of the cosmetic composition. When the content of rambutan extract is less than 0.001% by weight, the skin whitening effect is insignificant, and when it exceeds 10% by weight, the synergistic effect due to the excessive injection is not economical. Meanwhile, the rambutan extract may use a rambutan fruit extract including the pulp and the rind, and particularly, the rambutan rind extract is preferable in terms of skin whitening effect.
본 발명의 람부탄 추출물을 얻기 위한 추출방법은 다음과 같다. Extraction method for obtaining a rambutan extract of the present invention is as follows.
(a) 1차 추출단계(a) First extraction step
깨끗한 물로 세척한 람부탄을 마쇄하고 건조하여 건조물을 얻는다. 람부탄 건조물에 목 탄소수 1~4의 무수 또는 함수 저급 알코올 예를 들어 노르말프로판올, 이소프로판올, 물과 저급 알코올의 혼합물, 아세톤 및 1,3-부틸렌글리콜으로 이루어진 추출용매 중에서 하나 이상을 선택하여 5 내지 20배 부피량 부가한 다음 냉각콘덴서가 부착된 증류장치에서 50~200 ℃로 3 내지 24시간 동안 가열하여 추출한다. The rambutane washed with clean water is crushed and dried to obtain a dry product. In the rambutan dry matter, one or more anhydrous or hydrous lower alcohols having 1 to 4 carbon atoms, for example, normal propanol, isopropanol, a mixture of water and a lower alcohol, acetone and 1,3-butylene glycol are selected, and at least one is selected. 20 times by volume is added, and then extracted by heating to 50 ~ 200 ℃ for 3 to 24 hours in a distillation apparatus with a cooling capacitor.
(b) 숙성단계(b) ripening step
상기 (a) 단계의 추출액을 여과포로 여과한 후 그 여과액을 4~25 ℃에서 1~10일간 방치하여 숙성시켜 유효성분을 추출한다. After filtering the extract of step (a) with a filter cloth, the filtrate is left to mature for 1 to 10 days at 4 ~ 25 ℃ to extract the active ingredient.
(c) 2차 추출단계 (c) secondary extraction step
상기 (b) 단계의 숙성액을 여과한 후 냉각콘덴서가 부착된 증류장치에서 50~90 ℃로 감압농축한다. 농축액을 물에 분산한 후 에칠아세테이트, 디에틸에테르 및 메틸렌클로라이드로 이루어진 추출용매 중에서 하나 이상을 선택하여 분액깔때기에 넣고 1회 이상 추출한다. 물층을 분액깔때기에 넣고 에칠아세테이트, 디에틸 에테르 및 메틸렌클로라이드로 이루어진 추출용매 중에서 하나 이상을 선택하여 1회 이상 추출한다. After filtering the aging liquid of step (b) and concentrated under reduced pressure at 50 ~ 90 ℃ in a distillation apparatus with a cooling capacitor. The concentrated solution is dispersed in water, and at least one extractant consisting of ethyl acetate, diethyl ether and methylene chloride is selected and placed in a separatory funnel and extracted one or more times. The water layer is placed in a separatory funnel and at least one extraction solvent is selected from an extraction solvent consisting of ethyl acetate, diethyl ether and methylene chloride.
(d) 건조단계(d) drying step
상기 (c) 단계의 추출액 중 유기층을 모두 합하여 무수황산나트륨을 건조제로 하여 건조한 후 여과하여 감압농축한다. 그 농축액을 동결건조하거나 분무건조하여 람부탄 추출물을 얻는다. The organic layers in the extract of step (c) were combined, dried over anhydrous sodium sulfate as a drying agent, and filtered and concentrated under reduced pressure. The concentrate is lyophilized or spray dried to obtain a rambutan extract.
람부탄을 무수 또는 함수의 저급 알코올, 아세톤을 1차 추출용매로 하여 1차 추출한 후, 이러한 1차 추출용매 보다 낮은 극성의 용매인 에틸아세테이트, 디에텔에테르, 메틸렌클로라이드를 2차 추출용매로 하여 2차 추출함으로써 활성 성분의 함량을 증대시키고 불순물을 제거하여 안정도를 향상시킴과 아울러 람부탄 추출물의 미백효능을 극대화시킬 수 있게된다. Rambutane was first extracted with anhydrous or hydrous lower alcohol and acetone as primary extraction solvent, and then ethyl acetate, dietel ether and methylene chloride, which are solvents of lower polarity than the primary extraction solvent, were used as secondary extraction solvent. By extracting the tea, it is possible to increase the content of the active ingredient, remove impurities, improve stability, and maximize the whitening effect of the rambutan extract.
본 발명의 미백화장료 조성물은 화장품학 및 피부과학적으로 허용가능한 매질 및/또는 기제를 함유한다. 이는 국소적용에 적합한 모든 제형으로, 예를 들면 용액, 겔, 또는 고체 또는 반죽 무수 생성물, 수상에 유상을 분산시켜 얻은 에멀젼, 현탁액, 마이크로에멀젼, 마이크로캡슐, 미세과립구 또는 이온형(리포좀) 및/또는 비이온형의 소낭 분산제의 형태로, 또는 크림, 스킨, 로션, 파우더, 연고, 에센스, 스프레이 또는 콘실 스틱의 형태로 제공될 수 있다. 또한 본 발명에 따른 조성물은 포말(foam)의 형태로 또는 압축된 추진제를 더 함유한 에어로졸 조성물의 형태로도 사용될 수 있다. The whitening cosmetic composition of the present invention contains a cosmetically and dermatologically acceptable medium and / or base. These are all formulations suitable for topical application, for example emulsions, suspensions, microemulsions, microcapsules, microgranules or ionic (liposomes) obtained by dispersing an oil phase in a solution, gel or solid or pasty anhydrous product, aqueous phase and / or Or in the form of a nonionic vesicle dispersant, or in the form of a cream, skin, lotion, powder, ointment, essence, spray or cone stick. The composition according to the invention can also be used in the form of a foam or in the form of an aerosol composition further containing a compressed propellant.
본 발명의 조성물은 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품학 또는 피부과학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다. 이들 보조제는 화장품학 또는 피부과학 분야에서 일반적으로 사용되는 양으로 도입된다.Compositions of the present invention include fatty substances, organic solvents, solubilizers, thickening and gelling agents, emollients, antioxidants, suspending agents, stabilizers, foaming agents, fragrances, surfactants, water, ionic or nonionic emulsifiers. Cosmetics such as fillers, metal-ion sequestrants and chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic actives, lipid vesicles or any other ingredients commonly used in cosmetics or It may contain adjuvants commonly used in the field of dermatology. These adjuvants are introduced in amounts commonly used in the cosmetic or dermatological field.
이하 본 발명의 바람직한 실시예를 기재한다. 그러나 하기한 실시예는 본 발명의 바람직한 일 실시예일 뿐 본 발명이 하기한 실시예에 한정되는 것은 아니다.Hereinafter, preferred embodiments of the present invention will be described. However, the following examples are only one preferred embodiment of the present invention and the present invention is not limited to the following examples.
(실시예)(Example)
(실시예 1) (Example 1)
람부탄(Nephelium lappaceum L.)를 정제수로 세척하고 마쇄하여 건조시킨 다음 세말화한 람부탄(Nephelium lappaceum L.) 건조물 50g을 50% 에탄올 수용액 1ℓ에 넣고 냉각 콘덴서가 부착된 추출기에서 100 ℃로 12시간 끓여서 추출한 후 300메쉬 여과포로 여과하였다. 상기 여과액을 10 ℃에서 7일간 방치하여 숙성시킨 후 여과하였다. 그 여액을 냉각 콘덴서가 부착된 증류장치를 이용하여 60℃에서 감압 농축하여 농축액을 물 50㎖에 분산한 후 에틸아세테이트 100ℓ로 2차 추출하였다. 물층을 다시 분액 깔대기에 넣고 에틸아세테이트로 두 번 더 추출하였다. 분리된 유기층(에틸아세테에트층)을 모두 합하고 무수황산나트륨으로 건조한 후 여과하고 여액을 감압농축하고 농축액을 동결건조시켜 건조중량 5.4g을 얻었다. Wash the rambutan ( Nephelium lappaceum L.) with purified water, crush it, dry it, and then put 50 g of dried rambutan ( Nephelium lappaceum L.) in 1 L of 50% ethanol aqueous solution and boil it at 100 ° C for 12 hours in an extractor equipped with a cooling condenser. After extraction, the mixture was filtered through a 300 mesh filter cloth. The filtrate was left at 10 ° C. for 7 days to mature and filtered. The filtrate was concentrated under reduced pressure at 60 ° C. using a distillation apparatus equipped with a cooling condenser, and the concentrate was dispersed in 50 ml of water, and then extracted with 100 liters of ethyl acetate. The water layer was put back into the separating funnel and extracted twice more with ethyl acetate. The separated organic layers (ethyl acetate layer) were combined, dried over anhydrous sodium sulfate, filtered, the filtrate was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain a dry weight of 5.4 g.
(실시예2) Example 2
람부탄(Nephelium lappaceum L.)를 정제수로 세척하고 마쇄하여 건조시킨 다음 세말화한 람부탄(Nephelium lappaceum L.) 건조물 50g을 50% 에탄올 수용액 2ℓ에 넣고 냉각 콘덴서가 부착된 추출기에서 100 ℃로 12시간 끓여서 추출한 후 여과하였다. 상기 여과액을 10 ℃에서 7일간 방치하여 숙성시킨 후 여과하였다. 이 여과액을 80℃에서 냉각 콘덴서가 부착된 증류장치를 이용하여 감압 농축하고, 농축액을 물 200㎖에 분산한 후 3ℓ분액 깔대기에 넣고 메틸렌클로라이드 1.5ℓ 가한 뒤 흔들어서 잘 섞어준 다음 두층으로 완전히 분리된 후 메틸렌클로라이드층을 취하였다. 물층을 다시 분액 깔대기에 넣고 메틸렌클로라이드로 두 번 더 추출하였다. 분리된 유기층(메틸렌클로라이드층)을 모두 합한 뒤 무수황산나트륨을 넣어 건조한 후 여과하고 여액을 감압 농축하고 건조하여 건조중량 4.7g을 얻었다.After washing rambutan ( Nephelium lappaceum L.) with purified water, crushing and drying, 50 g of dried rambutan ( Nephelium lappaceum L.) dried in a 50% ethanol aqueous solution 2L and boiled at 100 ℃ in an extractor with a cooling condenser for 12 hours After extraction it was filtered. The filtrate was left at 10 ° C. for 7 days to mature and filtered. The filtrate was concentrated under reduced pressure using a distillation apparatus equipped with a cooling condenser at 80 ° C., the concentrate was dispersed in 200 ml of water, and placed in a 3 L separatory funnel, 1.5 L of methylene chloride was added, shaken well, and then completely separated into two layers. After the methylene chloride layer was taken. The water layer was put back into the separating funnel and extracted twice more with methylene chloride. The combined organic layers (methylene chloride layer) were combined, dried over anhydrous sodium sulfate, filtered and the filtrate was concentrated under reduced pressure and dried to obtain 4.7 g of dry weight.
(실시예 3) (Example 3)
람부탄(Nephelium lappaceum L.)의 과피를 정제수로 세척하고 마쇄하여 건조시킨 다음 세말화한 람부탄(Nephelium lappaceum L.) 건조물 50g을 50% 에탄올 수 용액 2ℓ에 넣고 냉각 콘덴서가 부착된 추출기에서 100 ℃로 12시간 끓여서 추출한 후 여과하였다. 여과액을 10 ℃에서 7일간 방치하여 숙성시킨 후 여과한다. 여과액을 80 ℃에서 냉각 콘덴서가 부착된 증류장치를 이용하여 감압 농축하고 농축액을 물 200㎖에 분산한 후 3ℓ분액 깔대기에 넣고 디에틸에테르 1.5ℓ를 가한 뒤 흔들어서 잘 섞어준 다음 두층으로 완전히 분리된 후 디에틸에테르 층을 취하였다. 물층을 다시 분액 깔대기에 넣고 디에틸에테르로 두 번 더 추출하였다. 분리된 유기층(디에틸에테르층)을 모두 합한 뒤 무수황산나트륨을 넣어 건조한 후 여과하고 여액을 감압 농축하고 건조하여 건조중량 4.5g을 얻었다.Wash the skin of rambutan ( Nephelium lappaceum L.) with purified water, crush it, dry it, and then put 50 g of dried rambutan ( Nephelium lappaceum L.) in 2 l of 50% ethanol water solution to 100 ° C in the extractor with cooling condenser. Boil for 12 hours, extract and filter. The filtrate is left at 10 ° C. for 7 days to mature and then filtered. The filtrate was concentrated under reduced pressure using a distillation apparatus equipped with a cooling condenser at 80 ° C., the concentrate was dispersed in 200 ml of water, placed in a 3 L separatory funnel, 1.5 L of diethyl ether was added, shaken well, and then completely separated into two layers. After taking the diethyl ether layer. The water layer was put back into the separating funnel and extracted twice more with diethyl ether. The combined organic layers (diethyl ether layer) were combined, dried over anhydrous sodium sulfate, dried and filtered. The filtrate was concentrated under reduced pressure and dried to obtain 4.5 g of dry weight.
(실시예 4) (Example 4)
람부탄(Nephelium lappaceum L.)를 정제수로 세척하고 건조시킨 다음 세말화한 람부탄(Nephelium lappaceum L.) 건조물 50g을 80% 에탄올 1ℓ에 넣고 냉각 콘덴서가 부착된 추출기에서 90 ℃로 12시간 끓여서 추출한 후 여과하였다. 여과액을 10 ℃ 에서 7일간 방치하여 숙성시킨 후 여과하였다. 이 여과액을 감압 농축하고 건조하여 건조중량 5.8g을 얻었다. Washed and dried rambutan (Nephralium lappaceum L.) with purified water, and dried 50 g of dried rambutan ( Nephelium lappaceum L.) in 1 l of 80% ethanol, extracted by boiling at 90 ° C for 12 hours in an extractor equipped with a cooling condenser. It was. The filtrate was left at 10 ° C. for 7 days to mature and filtered. The filtrate was concentrated under reduced pressure and dried to obtain a dry weight of 5.8 g.
(실시예 5) (Example 5)
람부탄(Nephelium lappaceum L.)를 정제수로 세척하고 건조시킨 다음 세말화한 람부탄(Nephelium lappaceum L.) 건조물 100g을 80% 메탄올 5ℓ에 넣고, 실온에서 24시간 침적하여 추출한 후 여과하였다. 잔사를 같은 방법으로 1회 더 추출하였 다. 각각의 추출액을 합하고 불용성물질을 제거한 후, 감압농축하고 건조하여 건조 중량 11.2g을 얻었다. Rambutane ( Nephelium lappaceum L.) was washed with purified water, dried, and then 100 g of dried rambutan ( Nephelium lappaceum L.) dried in 5 L of 80% methanol, which was deposited at room temperature for 24 hours, and filtered. The residue was extracted once more in the same way. Each extract was combined and the insoluble matters were removed, concentrated under reduced pressure and dried to give a dry weight of 11.2 g.
이하, 본 발명에 따른 람부탄 추출물의 피부 안전성 및 피부 미백작용을 알아보기 위해 하기와 같은 실험을 수행하였다. Hereinafter, the following experiment was performed to determine the skin safety and skin whitening effect of the rambutan extract according to the present invention.
(실험예)Experimental Example
(실험예 1) Experimental Example 1
(람부탄(Nephelium lappaceum L.)건조물 추출물의 안전성)(Safety of the Extract of Ramphetan ( Nephelium lappaceum L.)
화장료의 원료는 인체에 사용되기 때문에 무엇보다도 인체에 대한 안전성이 중요하다. 따라서 람부탄 건조물 추출물의 인체에 대한 독성 및 자극성 유무를 알아보기 위해 아래와 같은 실험을 수행하였다. 실시예 1의 람부탄 추출물을 프로필렌글리콜/에탄올(8/2)에 10% 농도로 만든 용액을 가지고 수행하였다.Since raw materials for cosmetics are used in the human body, safety for the human body is important above all. Therefore, the following experiment was performed to determine the toxicity and irritation of the rambutan dried extract to the human body. The rambutan extract of Example 1 was performed with a solution made at 10% concentration in propylene glycol / ethanol (8/2).
1) 급성경구 독성실험 (Acute oral toxicity test in mice) : 시험물질 1㎖/Kg을 암수 각 5마리씩 10마리의 쥐에 투여한 결과, 사망동물은 관찰되지 않았고 투여 전후의 체중변화도 유의할 차이가 관찰되지 않았다.1) Acute oral toxicity test in mice: When 1 ml / Kg of test substance was administered to 10 rats of 5 males and 5 females, no dead animals were observed and there was a significant difference in body weight before and after administration. Not observed.
2) 피부1차 자극실험 (Primary skin irritation test) : 토끼 12마리에 시험물질 적용 24시간 전에 등 부위의 털을 제거하고 2.5 cm×2.5 cm 넓이에 0.1 ㎖씩 24 시간 동안 도포하여 관찰하였다. 관찰 결과 자극이 없는 것으로 판정되었다.2) Primary skin irritation test: Twelve rabbits were removed 24 hours before application of the test substance and observed by applying 0.1 ml each for 2.5 hours at 2.5 cm × 2.5 cm width. Observation determined that there was no stimulus.
3) 안점막 자극 시험 (Eye irritation test) : 토끼 9마리에 2 중량% 농도로 saline에 희석하여 동물 1마리당 0.1 ㎖씩 눈에 투여하였다. 실험 결과 각막, 홍채, 결막에 대한 특별한 안점막 자극반응을 나타내지 않았다.3) Eye irritation test (Eye irritation test): 9 rabbits were diluted in saline at a concentration of 2% by weight and administered to the eye 0.1 ml per animal. Experimental results showed no specific eye mucosal irritation to cornea, iris and conjunctiva.
4) 피부 감작성 실험 (Skin sensitization test) : Gunea pig 암수 각 3마리씩 6마리에 Magnusson과 Kligman의 시험방법에 따라 실시한 결과 홍반, 부종, 가피 형성 등의 피부이상 증상은 관찰할 수 없었다.Skin sensitization test: Skin sensitization test was performed in three of each of the three male and female gunea pigs according to Magnusson's and Kligman's test methods.
5) 인체 첩포 실험 (Human patch test) : 20~28세의 건강한 여성 30명을 대상으로 CTFA Guideline (The Cosmetic Toiletry and Fragrance Association, INC, Washington, D. C. 20036, 1991)에 따라 실시하였다. 그 결과 피부일차 자극 반응은 나타나지 않았다.Human patch test: Thirty healthy women aged 20 to 28 years were tested according to CTFA Guideline (The Cosmetic Toiletry and Fragrance Association, INC, Washington, D. C. 20036, 1991). As a result, skin primary irritation did not occur.
6) 누적 자극성 실험 (Repeat Insult Human Patch Test) : 인체 첩포 실험 대상자에게 CTFA Guideline 에 따라 실험한 결과 누적 자극 반응 및 감작 반응이 나타나지 않았다.6) Repeat Insult Human Patch Test: The cumulative stimulus response and sensitization response were not observed in human patch test subjects according to CTFA Guidelines.
독성 및 피부에 대한 안전성 실험에서 람부탄 추출물은 피부 자극이 거의 없어 피부 외용제로서 안전한 물질임을 확인할 수 있었다.In the toxicity and skin safety experiments, it was confirmed that rambutan extract was a safe substance for external application due to almost no skin irritation.
(실험예 2)Experimental Example 2
(피부색소 세포 티로시나제 활성 저해 효과) (Inhibitory effect on skin pigment cell tyrosinase activity)
10% FBS 가 함유된 DMEM을 배양액으로 하여 2개의 6-well plate에 2×105 cell/well, 96-well plate에 2×105 cell/well로 B16/F10 melanoma cell을 넣고 37oC를 유지하여 24시간 배양하였다. 여기에 실시예 1 내지 4 및 알부틴을 처리하여 5일간 배양하였다. 배양이 완료되면 Phosphate buffered saline(PBS)로 2회 세척하고 세포를 수확하고 원심분리하여 세포 침전물을 만들었다. 이 침전물을 lysis buffer(50mM sodium phosphate buffer(pH 6.8) containing 0.1mM PMSF and 1% Triton X-100)로 처리하여 세포를 파괴시키고, 원심분리하여 상층액을 취하였다. 이 상층액에 100mM sodium phosphate buffer(pH 6.5), 1.5mM L-tyrosine 용액과 상층액 적량을 혼합하고, 37℃에서 30분 유지한 후 490nm에서 흡광도를 측정하였다. 시료를 처리하지 않은 B16/F10 melanoma cell을 배양한 것을 대조군으로 하여 하기 수학식에 따라 시료 농도별 티로시나제 활성 저해율을 구한 후, 그 결과를 표 1에 나타내었다. Of DMEM with a 10% FBS containing the culture medium by two 6-well plate 2 × 10 5 cell / well, 96-well plate to put the 2 × 10 5 cell / well in B16 / F10 melanoma cell 37 o C to It was maintained for 24 hours. Here, Examples 1 to 4 and arbutin were treated and cultured for 5 days. When the incubation was completed, washed twice with Phosphate buffered saline (PBS), harvested cells and centrifuged to form a cell precipitate. The precipitate was treated with lysis buffer (50 mM sodium phosphate buffer (pH 6.8) containing 0.1 mM PMSF and 1% Triton X-100) to destroy cells, and centrifuged to obtain supernatant. 100mM sodium phosphate buffer (pH 6.5), 1.5mM L-tyrosine solution and the supernatant were mixed with the supernatant, and the absorbance was measured at 490nm after maintaining at 37 ° C for 30 minutes. After culturing B16 / F10 melanoma cells that were not treated with the sample as a control, the inhibition rate of tyrosinase activity for each sample concentration was determined according to the following equation, and the results are shown in Table 1 below.
[표 1] 티로시나제 억제 활성 TABLE 1 Tyrosinase Inhibitory Activity
상기 표 1 에서 보는 바와 같이, 람부탄 추출물인 실시예 1 내지 4는 티로시나제 활성 억제효과를 보였고, 미백화장품의 원료로 사용되는 알부틴과 비교하여 월등한 저해활성을 나타내었다. 또한, 본 발명에 따른 추출방법으로 추출된 실시예 1 내지 3은 1차 추출물인 실시예 4에 비해 우수한 티로시나제 억제활성을 보였고, 람부탄 과피 추출물인 실시예 3이 람부탄 과실 추출물인 실시예 1 내지 실시예 2 보다 우수한 티로시나제 억제확성을 나타내었다. As shown in Table 1, Examples 1 to 4 of the rambutan extract showed an inhibitory effect on tyrosinase activity and showed superior inhibitory activity compared to arbutin used as a raw material of a whitening cosmetic. In addition, Examples 1 to 3 extracted by the extraction method according to the present invention showed a superior tyrosinase inhibitory activity compared to Example 4 which is the primary extract, and Example 1 to Rambutan fruit extract, Examples 1 to 3, which were rambutan fruit extracts. Better tyrosinase inhibition accuracy than Example 2.
(실험예 3)Experimental Example 3
(멜라닌 생성 억제 효과) (Melanin production inhibitory effect)
10% FBS가 함유된 DMEM을 배양액으로 하여 2개의 6-well plate에 2×105 cell/well, 96-well plate에 2×105 cell/well로 B16/F10 melanoma cell을 넣고 37℃를 유지하여 24시간 배양하였다. 여기에 실시예 1 내지 4 및 알부틴을 처리하여 5일간 배양하였다. 배양이 완료되면 Phosphate buffered saline(PBS)로 2회 세척하고 세포를 수확하고 원심분리하여 세포 침전물을 만들었다. 이 침전물을 1N NaOH로 처리하여 세포내 멜라닌을 용해시켰다. 이 용액을 405nm에서 흡광도를 측정하고 시료를 처리하지 않은 B16/F10 melanoma cell을 배양한 것을 대조군으로 하여 시료의 멜라닌 생성량을 구하고 그 결과를 표 2에 나타내었다.Using DMEM containing 10% FBS as a culture medium, B16 / F10 melanoma cells were added at 2 × 10 5 cell / well in two 6-well plates and 2 × 10 5 cell / well in 96-well plate and maintained at 37 ° C. Incubated for 24 hours. Here, Examples 1 to 4 and arbutin were treated and cultured for 5 days. When the incubation was completed, washed twice with Phosphate buffered saline (PBS), harvested cells and centrifuged to form a cell precipitate. This precipitate was treated with 1N NaOH to lyse intracellular melanin. The solution was measured for absorbance at 405 nm, and cultured B16 / F10 melanoma cells, which were not treated with the sample, were used as a control to determine the amount of melanin produced in the sample, and the results are shown in Table 2.
[표 2] 멜라닌 생성 억제 효과 [Table 2] Melanin production inhibitory effect
상기 표 2에서 알 수 있는 바와 같이, 멜라닌을 생성하는 세포인 melanoma cell의 세포배양에서, 본 발명에 따른 람부탄 추출물이 멜라닌 생성 억제효과가 우수함을 알 수 있다. 또한 미백화장품의 원료로 사용되는 알부틴과 비교하여 월등한 저해활성을 나타내었으며, 1차 추출물인 실시예 4에 비해 본 발명에 따른 추출방법으로 추출된 실시예 1 내지 3은 우수한 멜라닌 생성 억제활성을 보였다. 한편, 람부탄 과피 추출물인 실시예 3이 람부탄 과실 추출물인 실시예 1 내지 2 보다 우수한 멜라닌 생성 억제활성을 나타내었다. As can be seen in Table 2, in the cell culture of melanoma cells that are melanin-producing cells, it can be seen that the rambutan extract according to the present invention has an excellent melanin production inhibitory effect. In addition, it showed superior inhibitory activity compared to arbutin used as a raw material of the whitening cosmetics, Examples 1 to 3 extracted by the extraction method according to the present invention compared to Example 4, the primary extract has excellent melanin inhibitory activity Seemed. On the other hand, Example 3, a rambutan fruit extract, exhibited better melanin inhibitory activity than Examples 1 to 2, a rambutan fruit extract.
(실험예 3)Experimental Example 3
(임상실험에 의한 미백효능 시험) (Whitening efficacy test by clinical experiment)
본 발명의 미백화장료 조성물의 임상 미백효능을 시험하기 위하여, 얼굴에 기미, 주근깨 등의 색소침착이 있어 고민하는 피검자 100명(각 시료당 20명)을 대상으로 실시예 1 내지 5와 기존의 알려진 미백제로 알려진 알부틴를 프로필렌글리콜/에탄올(8/2)의 비히클에 각각이 1%의 농도가 되게 녹여 아침 저녁에 각 1회씩 3개월간 매일 2회씩 얼굴의 기미부위에 바르게 하였다. In order to test the clinical whitening efficacy of the whitening cosmetic composition of the present invention, Examples 1 to 5 and known to the 100 subjects (20 people per sample) who suffer from pigmentation such as blemishes, freckles on the face Arbutin, known as a whitening agent, was dissolved in a vehicle of propylene glycol / ethanol (8/2) at a concentration of 1% and applied to the spots of the face twice daily for three months, once every morning and evening.
사용 후에 색소침착의 개선정도를 아래의 판정 기준에 따라서 판정하고, 그 결과는 표 3에 나타내었다.After use, the degree of improvement of pigmentation was determined according to the following criteria, and the results are shown in Table 3.
*미백효능 평가 기준* Evaluation criteria for whitening efficacy
효과 탁월: 색소침착이 거의 눈에 띄지 않게 되었다. Excellent effect: Pigmentation is hardly noticeable.
효과 있음: 색소침착이 아주 연해졌다.With effect: Pigmentation is very soft.
약간 효과 있음: 색소침착이 연해졌다. Slightly effective: Pigmentation is softened.
효과 없음: 변화 없음.No effect: no change.
[표 3]TABLE 3
상기 표 3에서 확인할 수 있는 바와 같이, 본 발명의 람부탄 추출물은 알부틴에 비해 임상 미백효능이 더욱 우수하며, 1차 추출물인 실시예 4 내지 5 보다 본 발명에 따른 추출방법으로 2차 추출물인 실시예 1 내지 3이 임상 미백효능이 더욱 우수함을 알 수 있다. As can be seen in Table 3, the rambutan extract of the present invention is more excellent in clinical whitening efficacy than arbutin, and the second extract by the extraction method according to the present invention than the primary extract Examples 4 to 5 It can be seen that 1 to 3 is more excellent clinical whitening efficacy.
이상의 실험예 1~3을 종합하여 볼 때, 본 발명의 람부탄 추출물은 피부흑과 과정에 관여하는 티로시나제의 활성을 억제함과 동시에 멜라닌 생성과정을 저해하 여 멜라닌 생성을 감소시킴을 알 수 있다. 또한 본 발명에 따른 추출방법으로 추출된 람부탄 추출물이 티로시나제 활성 억제능과 멜라닌 생성억제능이 더욱 우수함을 알 수 있다. In summation of the above Experimental Examples 1 to 3, it can be seen that the rambutan extract of the present invention reduces the melanin production by inhibiting the activity of tyrosinase involved in the skin process and at the same time inhibiting the melanin production process. In addition, it can be seen that the rambutan extract extracted by the extraction method according to the present invention is more excellent in inhibiting tyrosinase activity and inhibiting melanin production.
상기한 실험예들의 결과를 근거로 하여, 실시예 1의 람부탄 추출물을 함유하여 피부미백효과를 제공할 수 있는 가용화 제형과 유화 제형을 제시한다. 그러나, 본 발명의 조성물이 하기의 제조예에만 한정되는 것은 아니다.Based on the results of the above experimental examples, solubilized formulations and emulsified formulations which can provide the skin whitening effect by containing the rambutan extract of Example 1 are presented. However, the composition of the present invention is not limited only to the following preparation examples.
(조성물 제조예) (Production example)
(제조예 1 내지 3)(Production Examples 1 to 3)
(유화 제형)(Emulsification formulation)
[표 4]TABLE 4
유화제형의 제조방법은 다음과 같다. The manufacturing method of an emulsifier type is as follows.
1) 1 내지 9의 원료의 혼합물을 65~70℃로 가열하였다. 1) The mixture of the raw materials of 1-9 was heated at 65-70 degreeC.
2) 10의 원료를 상기 1)의 혼합물에 투입하였다. 2) 10 raw materials were added to the mixture of 1) above.
3) 11 내지 13의 원료의 혼합물을 65~70℃로 가열하여 완전히 용해시켰다. 3) The mixture of the raw materials of 11-13 was heated at 65-70 degreeC, and was completely dissolved.
4) 65~70℃ 가열하면서 상기 2)의 혼합물을 상기 3)의 혼합물에 서서히 첨가하면서 8,000rpm에서 2~3분간 유화시켰다. 4) The mixture of 2) was emulsified at 8,000 rpm for 2 to 3 minutes while the mixture of 2) was slowly added to the mixture of 3) while heating at 65 to 70 ° C.
5) 14의 원료를 소량의 물에 용해시킨 후 상기 4)의 혼합물에 첨가하고 2분 간 더 유화시켰다.5) The raw material of 14 was dissolved in a small amount of water, and then added to the mixture of 4) and emulsified for 2 minutes.
6) 15 내지 17의 원료를 각각 평량한 후 상기 5)의 혼합물에 넣고 30초간 더 유화시켰다.6) The raw materials of 15 to 17 were weighed, and then put into the mixture of 5) and emulsified for 30 seconds.
7) 상기 6)의 혼합물을 유화 후 탈기과정을 거쳐 25~35℃로 냉각시켜, 유화제형을 제조하였다. 7) After the mixture of 6) was emulsified and degassed and cooled to 25 ~ 35 ℃, an emulsion was prepared.
(제조예 4 내지 6)(Production Examples 4 to 6)
(가용화 제형)Solubilized Formulation
[표 5]TABLE 5
가용화 제형의 제조방법은 다음과 같다.The preparation of the solubilized formulation is as follows.
1) 2 내지 6의 원료를 상기 1의 정제수에 넣고 아직믹서를 이용하여 용해시켰다.1) The raw materials of 2 to 6 were put into purified water of 1 above and dissolved using a still mixer.
2) 8 내지 11의 원료를 상기 7의 알코올에 넣고 완전용해시켰다.2) The raw materials of 8 to 11 were put in the alcohol of 7 and completely dissolved.
3) 상기 2)의 혼합물을 상기 1)의 혼합물에 서서히 첨가하면서 가용화시켰다. 3) The mixture of 2) was solubilized with slow addition to the mixture of 1).
(실험예 4) Experimental Example 4
(제형의 안정성 시험) (Stability test of formulation)
상기에서 제조한 제조예 1 내지 6 의 제형에 대하여 화장품으로서 보존 안정성을 평가하였다. 보존 안정성을 확인하기 위하여 온도별 변화에 따른 안정성을 조사하고, 그 결과를 표 6에 나타내었다.The storage stability as a cosmetic was evaluated for the formulations of Preparation Examples 1 to 6 prepared above. In order to confirm the storage stability, the stability of the temperature change was investigated, and the results are shown in Table 6.
[표 6] 온도별 보존 안정성 [Table 6] Storage Stability by Temperature
상기 표 6의 결과로부터, 본 발명에 따른 제형은 보존 안정성이 우수함을 알 수 있었다. From the results of Table 6, it can be seen that the formulation according to the present invention is excellent in storage stability.
상기에서 설명한 바와 같이, 본 발명의 람부탄 추출물을 함유하는 미백화장료 조성물은 피부자극 없이 피부흑화과정에 관여하는 티로시나제를 억제함과 동시에 멜라닌 생성을 억제함으로써 피부미백효능이 우수하다. As described above, the whitening cosmetic composition containing the rambutan extract of the present invention is excellent in skin whitening effect by inhibiting tyrosinase involved in the skin blackening process without skin irritation and at the same time inhibiting melanin production.
또한 본 발명의 람부탄 추출물을 함유한 미백화장료 조성물은 가용화 기술을 이용한 유연화장수 등 수용성 화장품 또는 유화기술을 이용한 유화 화장품 제형으로 제공될 수 있고, 제형화된 경우에 보존 안정성도 우수하다. In addition, the whitening cosmetic composition containing the rambutan extract of the present invention can be provided as an emulsified cosmetic formulation using water-soluble cosmetics or emulsification technology, such as softening longevity using solubilization technology, it is also excellent storage stability when formulated.
아울러 본 발명의 람부탄 추출물의 제조방법에 따르면 추출물의 유효성분의 함량과 안전성을 높일 수 있다. In addition, according to the production method of rambutan extract of the present invention can increase the content and safety of the active ingredient of the extract.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020040054936A KR20060007083A (en) | 2004-07-14 | 2004-07-14 | Whitening cosmetic composition containing rambutan extract and rambutan extraction method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020040054936A KR20060007083A (en) | 2004-07-14 | 2004-07-14 | Whitening cosmetic composition containing rambutan extract and rambutan extraction method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20060007083A true KR20060007083A (en) | 2006-01-24 |
Family
ID=37118459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020040054936A Ceased KR20060007083A (en) | 2004-07-14 | 2004-07-14 | Whitening cosmetic composition containing rambutan extract and rambutan extraction method |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20060007083A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012020370A1 (en) * | 2010-08-10 | 2012-02-16 | Robert Vachy | Galvinoxyl derivative for use thereof against lipoprotein-enveloped viruses, in particular herpesviruses |
| WO2018203000A1 (en) | 2017-05-05 | 2018-11-08 | Basf Beauty Care Solutions France Sas | Use of anephelium lappaceum extract for increasing the firmness of the skin and/or of the mucous membranes |
| KR20190066460A (en) | 2017-12-05 | 2019-06-13 | 표수진 | Pharmaceutical composition comprising the seed extracts of rambutan as an effective component for prevention or treatment of diabetes and health functional food comprising the same |
| KR20190066478A (en) | 2017-12-05 | 2019-06-13 | 이은서 | Antimicrobial composition comprising the extracts of rambutan peel |
| FR3077493A1 (en) * | 2018-01-16 | 2019-08-09 | Basf Beauty Care Solutions France Sas | New cosmetic use of an extract of Nephelium lappaceum |
| KR20200035040A (en) * | 2017-08-02 | 2020-04-01 | 바스프 뷰티 케어 솔루션즈 프랑스 에스에이에스 | New cosmetic use of Nephelium rapaseum extract |
-
2004
- 2004-07-14 KR KR1020040054936A patent/KR20060007083A/en not_active Ceased
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012020370A1 (en) * | 2010-08-10 | 2012-02-16 | Robert Vachy | Galvinoxyl derivative for use thereof against lipoprotein-enveloped viruses, in particular herpesviruses |
| FR2963736A1 (en) * | 2010-08-10 | 2012-02-17 | Robert Vachy | THERAPEUTIC COMPOSITION COMPRISING GALVINOXYL DERIVATIVE AND PROPOLIS AND USE THEREOF FOR LIPID CAPSID VIRUSES, IN PARTICULAR HERPES VIRUSES |
| WO2018203000A1 (en) | 2017-05-05 | 2018-11-08 | Basf Beauty Care Solutions France Sas | Use of anephelium lappaceum extract for increasing the firmness of the skin and/or of the mucous membranes |
| US11517520B2 (en) | 2017-05-05 | 2022-12-06 | Basf Beauty Care Solutions France Sas | Use of a Nephelium lappaceum extract for increasing the firmness of the skin and/or of the mucous membranes |
| KR20200035040A (en) * | 2017-08-02 | 2020-04-01 | 바스프 뷰티 케어 솔루션즈 프랑스 에스에이에스 | New cosmetic use of Nephelium rapaseum extract |
| KR20200034954A (en) * | 2017-08-02 | 2020-04-01 | 바스프 뷰티 케어 솔루션즈 프랑스 에스에이에스 | Use of the extract of the skin of Nephelium rapaseum to hydrate the skin and / or mucous membranes |
| US11364193B2 (en) | 2017-08-02 | 2022-06-21 | Basf Beauty Care Solutions France S.A.S. | Cosmetic use of a Nephelium lappaceum extract |
| KR20190066460A (en) | 2017-12-05 | 2019-06-13 | 표수진 | Pharmaceutical composition comprising the seed extracts of rambutan as an effective component for prevention or treatment of diabetes and health functional food comprising the same |
| KR20190066478A (en) | 2017-12-05 | 2019-06-13 | 이은서 | Antimicrobial composition comprising the extracts of rambutan peel |
| FR3077493A1 (en) * | 2018-01-16 | 2019-08-09 | Basf Beauty Care Solutions France Sas | New cosmetic use of an extract of Nephelium lappaceum |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101387308B1 (en) | Skin whitening composition by using of dendropanax morbifera ferment extract | |
| KR20100043655A (en) | A cosmetic composition for stabilizing vitamin c | |
| KR102130571B1 (en) | Low irritating cosmetic composition for skin whitening comprising albutin and extract of Euterpe oleracea fruit | |
| KR102142311B1 (en) | Skin external composition comprising tangeretin | |
| KR100879900B1 (en) | Cosmetic composition for skin whitening containing the fruit berry extract as an active ingredient | |
| KR102525467B1 (en) | Skin external application composition for anti-aging containing Rhodotypos scandens extract | |
| KR101020536B1 (en) | Cosmetic composition for moisturizing skin containing cucumber extract and method for producing same | |
| KR20200072608A (en) | Cosmetic Composition For Skin Whitening Comprising Extract of Clitoria Ternatea Flower | |
| KR20240105664A (en) | Cosmetic composition for scalp soothing comprising mixture of Camellia japonica pericarp extract and Cynanchum atratum extract as an active ingredient | |
| KR102711814B1 (en) | Skin external application composition for anti-aging | |
| KR100564107B1 (en) | Cosmetic composition containing mixed plant extract having anti-aging effect | |
| KR20060007083A (en) | Whitening cosmetic composition containing rambutan extract and rambutan extraction method | |
| KR102226179B1 (en) | Cosmetic Compositions for Anti-aging Comprising Extracts of Plants | |
| KR20090056296A (en) | Composition for strengthening hair root and improving scalp condition containing herbal extract | |
| KR102525901B1 (en) | Skin external application composition for anti-aging containing Phlox subulata extract | |
| KR20130022476A (en) | A cosmetic composition containing extract of artemisia iwayomogi | |
| KR20200129888A (en) | Cosmetic composition containing black kelp | |
| KR20140114709A (en) | Composition for Improving Skin Conditions Comprising Boehmeria spicata (Thunb.) Thunb Extract | |
| KR100576653B1 (en) | Whitening Cosmetic Composition Containing Celadon Extract | |
| KR101083029B1 (en) | UV-absorbing cosmetic composition containing rice-derived embryo and rhubarb extract | |
| KR100946584B1 (en) | Cosmetic composition for astringent and skin irritation containing fruit extract and Blue Lotus extract | |
| KR102780319B1 (en) | Composition for improving hair scalp comprising Camellia japonica pericarp extract as an active ingredient | |
| KR102831785B1 (en) | Composition for Promoting Melanin synthesis comprising Sargassum fusiforme extract | |
| KR102840764B1 (en) | Composition for Promoting Melanin synthesis comprising Smilax china extract | |
| KR102895406B1 (en) | Composition for sensitive skin comprising extracts of Rhaponticum Carthamoides, Clitoria ternatea, and Curcuma longa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20040714 |
|
| PA0201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20051220 Patent event code: PE09021S01D |
|
| PG1501 | Laying open of application | ||
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20060303 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20051220 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |